These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Meeting the challenge of recurrent Clostridium difficile infection. Johnson S J Hosp Med; 2012 Mar; 7 Suppl 3():S11-3. PubMed ID: 22407994 [TBL] [Abstract][Full Text] [Related]
3. The changing face of Clostridium difficile: what treatment options remain? Shen EP; Surawicz CM Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108 [TBL] [Abstract][Full Text] [Related]
5. Current strategies for management of initial Clostridium difficile infection. Kelly CP J Hosp Med; 2012 Mar; 7 Suppl 3():S5-10. PubMed ID: 22407996 [TBL] [Abstract][Full Text] [Related]
6. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection? Kuijper EJ; Wilcox MH Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959 [No Abstract] [Full Text] [Related]
7. Increase in use of vancomycin for Clostridium difficile infection in US hospitals. Pakyz AL; Carroll NV; Harpe SE; Oinonen M; Polk RE Infect Control Hosp Epidemiol; 2010 Aug; 31(8):867-8. PubMed ID: 20586649 [No Abstract] [Full Text] [Related]
8. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection. Saffouri G; Khanna S; Estes L; Pardi D Am J Gastroenterol; 2014 Jun; 109(6):924-5. PubMed ID: 24896763 [No Abstract] [Full Text] [Related]
9. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Bartlett JG Clin Infect Dis; 2008 May; 46(10):1489-92. PubMed ID: 18419480 [No Abstract] [Full Text] [Related]
10. [Occurrence and treatment of Clostridium difficile-associated diarrhea]. Tvede M; Høiby N Ugeskr Laeger; 2006 Jun; 168(26-32):2579; author reply 2579-80. PubMed ID: 16824400 [No Abstract] [Full Text] [Related]
11. Metronidazole and vancomycin: equivalence of initial efficacy in CDAD. Burman LG Am J Gastroenterol; 2008 Aug; 103(8):2147; author reply 2147. PubMed ID: 18796117 [No Abstract] [Full Text] [Related]
12. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327 [TBL] [Abstract][Full Text] [Related]
14. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology, diagnosis and treatment of Clostridium difficile infection. Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319 [TBL] [Abstract][Full Text] [Related]